South State Corp Eli Lilly & CO Transaction History

South State Corp

$1.45 Billion
Q3 2024

A detailed history of South State Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, South State Corp holds 11,133 shares of LLY stock, worth $8.86 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

11,133

Previous 11,883 6.31%

Holding current value

$8.86 Million

Previous $10.8 Million 8.32%

% of portfolio

0.68%

Previous 0.79%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$772.14 - $960.02 $579,105 - $720,015	-750 Reduced 6.31%	11,133 $9.86 Million
Q2 2024 Aug 02, 2024	SELL	$724.87 - $909.04 $1.13 Million - $1.42 Million	-1,563 Reduced 11.62%	11,883 $10.8 Million
Q1 2024 May 06, 2024	SELL	$592.2 - $792.28 $172,922 - $231,345	-292 Reduced 2.13%	13,446 $10.5 Million
Q4 2023 Feb 06, 2024	SELL	$525.19 - $619.13 $224,781 - $264,987	-428 Reduced 3.02%	13,738 $8.01 Million
Q3 2023 Nov 07, 2023	SELL	$434.7 - $599.3 $367,756 - $507,007	-846 Reduced 5.64%	14,166 $7.61 Million
Q2 2023 Aug 08, 2023	SELL	$350.74 - $468.98 $709,547 - $948,746	-2,023 Reduced 11.88%	15,012 $7.04 Million
Q1 2023 May 08, 2023	SELL	$310.63 - $364.82 $722,525 - $848,571	-2,326 Reduced 12.01%	17,035 $5.85 Million
Q4 2022 Feb 10, 2023	SELL	$321.55 - $374.67 $345,987 - $403,144	-1,076 Reduced 5.26%	19,361 $7.08 Million
Q3 2022 Nov 07, 2022	BUY	$296.48 - $337.87 $19,567 - $22,299	66 Added 0.32%	20,437 $6.61 Million
Q2 2022 Aug 05, 2022	BUY	$278.73 - $327.27 $210,998 - $247,743	757 Added 3.86%	20,371 $6.61 Million
Q1 2022 May 06, 2022	BUY	$234.69 - $291.66 $262,383 - $326,075	1,118 Added 6.04%	19,614 $5.62 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $117,146 - $145,379	521 Added 2.9%	18,496 $5.11 Million
Q3 2021 Nov 10, 2021	SELL	$221.6 - $272.71 $49,195 - $60,541	-222 Reduced 1.22%	17,975 $4.15 Million
Q2 2021 Aug 10, 2021	SELL	$180.55 - $233.54 $105,802 - $136,854	-586 Reduced 3.12%	18,197 $4.18 Million
Q1 2021 May 12, 2021	SELL	$164.32 - $212.72 $15,939 - $20,633	-97 Reduced 0.51%	18,783 $3.51 Million
Q4 2020 Feb 10, 2021	SELL	$130.46 - $172.63 $40,051 - $52,997	-307 Reduced 1.6%	18,880 $3.19 Million
Q3 2020 Nov 10, 2020	SELL	$146.22 - $169.13 $370,667 - $428,744	-2,535 Reduced 11.67%	19,187 $2.84 Million
Q2 2020 Aug 11, 2020	BUY	$136.42 - $164.18 $720,297 - $866,870	5,280 Added 32.11%	21,722 $3.57 Million
Q1 2020 May 04, 2020	SELL	$119.05 - $147.35 $242,504 - $300,151	-2,037 Reduced 11.02%	16,442 $2.28 Million
Q4 2019 Feb 05, 2020	SELL	$106.92 - $132.43 $58,378 - $72,306	-546 Reduced 2.87%	18,479 $2.43 Million
Q3 2019 Nov 08, 2019	SELL	$106.79 - $116.16 $894,900 - $973,420	-8,380 Reduced 30.58%	19,025 $2.13 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $119,985 - $140,053	-1,083 Reduced 3.8%	27,405 $3.04 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $46,193 - $54,373	-415 Reduced 1.44%	28,488 $3.7 Million
Q4 2018 Feb 11, 2019	BUY	$105.9 - $118.64 $36,535 - $40,930	345 Added 1.21%	28,903 $3.34 Million
Q3 2018 Nov 08, 2018	SELL	$85.86 - $107.31 $222,634 - $278,254	-2,593 Reduced 8.32%	28,558 $3.07 Million
Q2 2018 Aug 03, 2018	SELL	$75.7 - $86.88 $44,284 - $50,824	-585 Reduced 1.84%	31,151 $2.66 Million
Q1 2018 May 11, 2018	BUY	$74.21 - $87.6 $12,912 - $15,242	174 Added 0.55%	31,736 $2.46 Million
Q4 2017 Feb 12, 2018	BUY	$81.94 - $87.89 $111,520 - $119,618	1,361 Added 4.51%	31,562 $2.67 Million
Q3 2017 Nov 09, 2017	SELL	$77.07 - $85.54 $35,760 - $39,690	-464 Reduced 1.51%	30,201 $2.58 Million
Q2 2017 Aug 10, 2017	BUY	N/A	30,665	30,665 $2.52 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of South State Corp, based on Form 13F filings with the SEC.

News

Stay updated on South State Corp with notifications on news.

Account